Physician profile
Terrence G Ishmael
NPI 1952698896
$10,485.36
in general payments reported to CMS, 2019-2025
10 companies · $4,048 in 2025
The $4,048 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.73 · 2020: $113 · 2021: $1,064 · 2022: $635 · 2023: $568 · 2024: $3,993 · 2025: $4,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,056 · Consulting Fee: $2,820 · Food and Beverage: $1,732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,056.17 |
| Consulting Fee | $2,820.00 |
| Food and Beverage | $1,731.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $3,830.13 | 2024-2025 | Other - Miscellaneous, Invictus Mis, Invictus Open |
| Depuy Synthes Products, INC. | $3,683.98 | 2025 | |
| Stryker Corporation | $1,408.43 | 2021-2025 | N/A, Capri Corpectomy Cage System, Bio Dbm |
| Nuvasive, INC. | $651.68 | 2019-2023 | Reline |
| Brainlab, INC. | $322.12 | 2022 | |
| Zimvie INC. | $288.75 | 2022-2023 | |
| Biomarin Pharmaceutical INC. | $146.41 | 2023-2024 | Voxzogo 1.2mg |
| Depuy Synthes Sales INC. | $108.48 | 2021-2025 | Expedium |
| Paladin Technology Solutions | $26.90 | 2023 | |
| Vb Spine LLC | $18.48 | 2025 | Everest Spinal System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Ishmael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.